DRUG · GROUP
MECHANISM
USE
KEY POINTS
Direct renin inhibitor → ↓ angiotensin I
Hypertension
Not with ACEi/ARB (diabetes) · ↑ K⁺, teratogenic
Block ACE → ↓ AT II, ↓ aldosterone, ↑ bradykinin; ↑ renin (loss of feedback)
HTN, HFrEF, diabetic nephropathy, post-MI
Cough, angioedema, ↑ K⁺, ↑ creatinine, fetal renal damage
AT1 receptor antagonist; ↑ AT II and renin
Same as ACEi
No bradykinin effects; losartan uricosuric
Mineralocorticoid antagonists
Block aldosterone at collecting duct
Hyperaldosteronism, HF, ascites
↑ K⁺, antiandrogen (spironolactone)
IV calcium gluconate/chloride
ECG changes (peaked T, wide QRS)
Doesn't lower K⁺; works in minutes
Insulin (+ glucose), albuterol, sodium bicarbonate
Temporary K⁺ entry into cells (Na⁺/K⁺-ATPase)
Watch hypoglycemia
Loop diuretic, patiromer, sodium zirconium cyclosilicate, sodium polystyrene sulfonate, dialysis
Total-body K⁺ elimination
Binders work in hours; dialysis definitive
Sevelamer, calcium acetate/carbonate, lanthanum
Hyperphosphatemia of CKD
Calcium binders → hypercalcemia, vascular calcification
Active vitamin D · ↑ Ca²⁺-sensing receptor sensitivity → ↓ PTH
Secondary hyperparathyroidism
Cinacalcet → hypocalcemia
Erythropoiesis-stimulating agents
Epoetin, darbepoetin
Anemia of CKD (give iron too)
Hypertension, thrombosis; target Hb ≤ 11–12
Alkalinizes urine; citrate chelates Ca²⁺
Calcium oxalate, uric acid and cystine stones
Hyperkalemia in CKD
Hemodynamic: NSAIDs, ACEi, calcineurin inhibitors · tubular: aminoglycosides, amphotericin, cisplatin, contrast · interstitial: penicillins, PPIs · crystals: acyclovir, methotrexate, indinavir
—
Hydrate, dose by GFR, avoid combinations